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R522found in the hemolymph of mated
wild-type females where it is degraded
into smaller non-functional peptides
[19]. Taken together with the almost
ubiquitous distribution of the SPR (see
above) to many peripheral neurons and
specific parts of the VNC and the brain
[13], these findings suggest that SP
may have additional effects. The dsx+
/fru+/ppk+ neurons are very likely the
primary targets. But SP entered into
the hemolymph may in addition act
by modulating the activity of the SP
circuitry by modifying sensory input via
binding to afferent nerve axons
and/or directly on presynaptic
terminals [7,14–16]. Finally, stimulation
of juvenile hormone synthesis and
inducing the immune response in
various organs very likely occurs via
SP entered into the hemolymph [7].
In sum, Rezaval et al. [3] have
identified ascending neurons that
target the brain, local interneurons and
descending neurons that innervate the
reproductive system. All express dsx
and are involved in the SP response,
hence confirming that fru and dsx are
involved in establishing sexual
dimorphic features of neural circuitry
in fruit flies [1]. This is a major step
towards understanding the complex
function of a fascinating small male
peptide. It will be interesting to learn
how fru and dsx shape the
development of the relevant neuronal
circuitries.References
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a Day Keeps the Cancer at BayLive imaging of the interactions between oncogene-transformed cells and
leukocytes in zebrafish reveals that PGE2 promotes the survival and
proliferation of cancer cells. Non-steroid anti-inflammatory drugs, like aspirin,
are the effective inhibitors of PGE2 production and could be used with other
anti-tumor agents in the treatment of cancer.Marina Mione1 and Leonard I. Zon2
The relationship between cancer and
inflammation has been a hot subject in
research and medicine for centuries.
The original observations by Galenius
(2000 b.C), Virchow [1] and Dvorak [2]
all suggested a close link between
inflammation and cancer. As
leukocytes are the first line of defensein immune responses, their presence in
tumors has been hypothesized to have
anti-cancer activity. In recent years, it
has become clear, however, that the
majority of tumor-associated
leukocytes are there to promote tumor
growth, tumor angiogenesis, invasion
and metastasis. Two years ago, in
a paper published in PLoS Biology,
Feng et al. [3] reported thatoncogene-transformed cells are able to
attract leukocytes immediately after
transformation, demonstrating an early
trophic support provided by leukocytes
to growing tumors. In a new study
reported in this issue of Current
Biology, Feng et al. [4], using the same
cancer model, now identify the signal
that leukocytes provide to cancer cells
to promote their survival.
To address these questions, Feng
et al. [4] used genetic tools and
chemical inhibitors to image cancer
and inflammation in transparent
zebrafish larvae. These authors
employed a novel model of
oncogene-induced transformation that
targets a population of very superficial
cells (the mucous-producing cells of
the skin). These single cells, closely
related to sebaceous gland mucous
Figure 1. PGE2 produced by leukocytes near cancer cells acts as a pro-survival signal through the EP1 receptor.
(A) The pathways involved in eicosanoid metabolism in the cytoplasm of a leukocyte approaching a cancer cell are shown, together with the
chemical or genetic (morpholino) inhibitors that block specific enzymes. (B) Different PGE2 receptors (EP1–4) and their association with specific
G-protein subunits lead to the activation of different pathways. Protein kinase A (PKA) activation downstream of EP2 or EP4 signaling stabilizes
b-catenin (Wnt) and P-ERK (Ras) signals to increase proliferation. EP1 receptors were also found in a perinuclear compartment, where other, as
yet unknown mechanisms may lead to transcriptional and epigenetic changes. See text for details and references.
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R523cells in mammals and sparse in the
epidermis of zebrafish larvae, respond
to oncogene expression by rapid,
uncontrolled proliferation [5]. In their
previous study, Feng et al. [3] had
documented that the ability of
transformed cells to attract leukocytes
through a H2O2 signal was beneficial to
tumor cells, given that, in the absence
of leukocytes, transformed cells did not
proliferate and instead underwent
apoptosis. The big question that
remained unsolved in this earlier study
was the nature of the trophic signal
released by leukocytes that permitted
growth of the transformed cells. In the
new work, the search for the trophic
signal ended with an interesting
candidate, the eicosanoid
prostaglandin E2 (PGE2), which has
been involved in inflammation and
cancer (reviewed in [6]) and has a long
history of helping cancer cells to
survive, proliferate and invade [7].
Besides confirming the ‘usual suspect’
in a novel model of cancer-induced
inflammation, the strongest points of
the study lie in the use of combined
genetic approaches and small
chemical inhibitors to confirm the
involvement of PGE2 and its receptor
E-prostanoid 1 (EP1) in the trophic
support to transformed cells.
The authors use chemical inhibitors
and morpholinos to knock down the
enzymatic activities producing PGE2
and pinpoint the specificpathway — namely microsomal rather
than cytoplasmic PGEs — used by
leukocytes to produce PGE2 in the
vicinity of Ras-transformed cells
(Figure 1A). To overcome the
problem of early lethality due to
morpholino-mediated ablation of
microsomal PGEs, they ‘rescued’ PGE2
signaling during the first 9 hours of
development by incubating embryos
with the long-acting derivative of PGE2,
16,16-dimethyl-PGE2 (dmPGE2).
This trick allowed them to study the
effects of removing PGE2 when
oncogene-transformed cells most
needed it, i.e. from the very
beginning of transformation. Elegant
lineage ablation studies and live
observations in neutrophil- and
macrophage-specific transgenic lines
shed light on which of the two
leukocyte cell populations contribute
trophic PGE2 to cancer cells. The
answer is that PGE2 is the only trophic
signal produced by macrophages,
whereas neutrophils contribute
additional as yet unknown trophic
products. Because of these detailed
characterizations of the enzymatic
pathway and of the innate immune
cell populations involved, the study
is likely to provide significant hints
for advancing the search for
specific drugs targeting the
inflammation–cancer link.
Several questions are raised by this
study and remain unresolved, with theexciting possibility of using the same or
similarmodels to find the answers. First
of all, how is PGE2, signaling through
the EP1 receptor, sustaining cancer
growth? There are studies reporting
a role of PGE2 in promoting Akt
phosphorylation in neuroblastoma
cells through calcium waves and cyclic
AMP (cAMP) production [8] through
different PGE2 receptors. The four EP
receptors (EP1–4) have multiple
localizations (being found in the cell
membrane, cytoplasm or nucleus),
each related to specific downstream
pathways in PGE2 signaling (Figure 1B).
Although these receptors are not
mutually exclusive, their combinatorial
expression or activation may lead to
different outcomes. The possibility of
using an in vivo model equipped with
a wealth of genetic and chemical
biology tools to tease apart the roles
of different EP receptors in cancer is
extremely exciting.
A recent report attributed to PGE2 the
repression of the DNA demethylases
Dnmt1 and Dnmt3b and the
corresponding increase in methylation
of tumor suppressors in ApcMin/+ mice
[9] as a mechanism to promote
cancer. These mice are well known
to PGE2 aficionados as it was
previously shown that lifetime
administration of aspirin to these mice
suppressed their intestinal and
mammary tumors [10]. However, the
mechanisms of Dnmt1/Dnmt3b
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clarified.
The ApcMin/+ mice provide a model
for familial polyposis, a fairly common
disease associated with APC
mutations and cancer predisposition.
Here the multiple adenomas forming in
the colon of affected patients are
sustained by increased Wnt signaling.
Non-steroid anti-inflammatory drugs
(NSAIDs) are commonly used for the
treatment of familial polyposis, and
reduction of PGE2 levels with
cyclo-oxygenase (COX) inhibitors has
proven effective in suppressing
increased Wnt signaling [11].
One of the most tantalizing reports
on the cancer-promoting function of
PGE2 is that of the activation of a
Ras–MAPK–P-ERK cascade in APCMin
mice bearing intestinal adenomas [12].
This is due to a self-amplifying loop that
mimics activated Ras and relies on the
induction of COX-2 in adenoma cells. It
is possible that PGE2, locally produced
by leukocytes, may have the same
effect as the externally provided PGE2
on tumor cells. Clearly, dissecting the
different mechanisms through which
PGE2 ensures support to cancer cells
may open up new avenues for
intervention.
Another question is related to the
expression of the PGE2 receptors. It
would be useful to know whether EP1
and other receptors are induced by
the oncogene, as a means to provide
transformed cells with the ability to
respond to leukocyte PGE2. The
implications of Ras-induced EP1
receptor expression are multiple.
Besides representing an early marker
of transformation, its selective
blockage may have amplified
responses in cancer prevention as
this may be the key point in the
PGE2–Ras activation loop. This loop
is mostly mediated by a cAMP
response induced by EP2/EP4
activation (Figure 1B), whereas early
transformed cells in this model seem
to express nuclear EP1. How do
PGE2 nuclear receptors regulate
transcription or other nuclear events?
One possibility is the convergence
of EP1-mediated signals on Wnt
target genes, which are induced by
nuclear b-catenin accumulation.
Indeed, the same EP2/EP4-mediated
PKA and cAMP accumulation, which
sustains the PGE2–Ras loop, is
responsible for further stabilization of
b-catenin [11] downstream of PGE2
signaling (Figure 1B).Can we prevent cancer by targeting
the pathways downstream of PGE2?
While the overlapping molecular
pathways described earlier provide
experimental support for this
possibility, the ‘proof of principle’ that
targeting innate inflammatory
responses in cancer will have
anti-tumor effects comes from clinical
evidence. Treating chronic
inflammation in patients often led to
regression of associated cancer, and
long-term supply of regular aspirin or
other NSAID therapies for the
prevention of cardiovascular disorders
strongly decreased the incidence of
cancer in a large cohort study [13]. In
a mouse model of acute myeloid
leukemia, the reversible COX inhibitor
indomethacin was shown to strongly
reduce leukemia-initiating cells
through repression of Wnt–b-catenin
signaling [14]. NSAIDs function by
inhibiting COX-1 and COX-2, which
are responsible for the production of
all prostaglandins from fatty acids
(Figure 1A), but the processes that
are affected by a reduction of
prostaglandin levels are too
numerous to be specific for the
cancer–inflammation axis. For
example, prostaglandins regulate
hormonal activities, coagulation,
angiogenesis, vasodilation [15] and
hematopoietic stem cell homing and
transplantation [16], just to mention
a few.
The wide range of actions of NSAIDs
explains the decision not to pursue
a clinical trial in cancer patients, in spite
of the impressive clinical data gathered
by Rothwell et al. [13], which revealed
a reduction by 30–60% of the 20-year
risk of cancer death. Most importantly,
the reasons for the premature drop in
the use of NSAIDs in cancer prevention
came from the dramatic outcome
of gastrointestinal bleeding and
increased thrombocytic events that
accompanied the long-term usage of
NSAIDs and specific COX-2 inhibitor
derivatives in cardiovascular disease
prevention trials [17]. Studies like the
report by Feng et al. [4] will contribute
a great deal to develop cancer-specific
anti-PGE2 therapies.
Ultimately, this latest report from
Feng et al. [4] provides a novel
perspective on inflammation and
cancer: usually this complex
relationship has been tackled from the
point of view of infectious agents as
cancer inducers (viruses or bacteria
through inflammation) or cancerco-factors (inflammation). Here,
cancer-initiating cells (expressing an
oncogene) are inflammatory (most
likely in advanced cancer [18]), even
before any morphological or behavioral
difference from their untransformed
siblings becomes apparent. The new
study also provides the hope that
altering prostaglandin levels can help
prevent cancer.
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Unorthodox ReproductionAn unusual reproductive system was discovered in desert ants, in which
daughter queens are produced asexually via parthenogenesis, whereas
workers develop from hybrid crosses between genetically divergent lineages.
The system appears to be doomed to extinction.Tanja Schwander1,*
and Laurent Keller2
Although species are commonly
defined as groups of shared
reproduction, many species do
form hybrids in nature. In most
cases, these hybrids are infertile
and perish in one generation, but
some hybrid species have escaped
this constraint by acquiring unusual
reproductive modes. Several
hybrid species of fish, stick insects
and frogs consist only of females
and rely on males of closely related
species to fertilize their eggs.
When such hybrid females produce
eggs themselves, they selectively
discard the chromosomes inherited
from their father to only transmit the
genetic material of their mother [1].
In such cases, referred to as
‘hybridogenesis’, females thus
asexually transmit their maternal
genome to the next generation,
while males are only used as
‘sperm donors’ for the production
of the soma.
A new paper in this issue of Current
Biology [2] now describes a social
version of hybridogenesis. In the
desert ant Cataglyphis hispanica
(Figure 1A), queens use alternative
modes of reproduction to produce
reproductive daughter queens
and the non-reproductive workers,
which are necessary for the
maintenance and survival of the colony.
All daughter queens are producedasexually via parthenogenesis while
workers are sexually produced from
hybrid crosses between two
genetically distinct lineages. Each of
the two lineages has a set of private
microsatellite alleles, indicating that
they are independently evolving
entities with little or no gene flow
between them.
Social and Non-Social Hybridogenesis
There are striking similarities between
this system of ‘social hybridogenesis’
and the known systems of (non-social)
hybridogenesis. In both systems,
sperm is used only to produce
individuals (the workers) or cells
(somatic cells) that do not contribute to
the transmission of genetic material
between generations. However, two
important features distinguish the
system of social hybridogenesis in
C. hispanica from its non-social
version: first, instead of having one
species depending on the presence of
males of another species to reproduce
(normal hybridogenesis), both lineages
of C. hispanica need each other to
obtain the sperm required for the
production of workers; second, both
C. hispanica lineages still produce
males while males are entirely absent
from non-social hybridogenetic
species.
Although the C. hispanica
reproductive system most closely
mirrors non-social hybridogenesis,
the term social hybridogenesis was
originally coined for a reproductivesystem in Pogonomyrmex harvester
ants [3,4] where at least eight divergent
lineages co-occur in specific
lineage-pairs [5]. Queens mate
multiply with males of their own and
of the alternative lineage; offspring
produced from same-lineage
matings always develop into queens,
whereas inter-lineage hybrids
develop into workers [3,4,6,7]. Thus,
while in both C. hispanica and
Pogonomyrmex workers are produced
from crosses between divergent
lineages, the two systems differ in
how queens are produced: by normal
sexual reproduction in Pogonomyrmex
and via parthenogenesis in
C. hispanica.
Four additional ant species have
been shown to have reproductive
systems relying on hybridization
between species or lineages for
worker production. Similarly to
Pogonomyrmex, Solenopsis xyloni
workers are produced from matings
with a different species (S. geminata)
while within-species fertilizations give
rise to new queens [8]. The difference
is that S. xylony colonies comprise
multiple queens each mated with
a single male. Thus, queens produce
exclusively new queens or workers
depending on the male they
mated with. In the three remaining
species — Wasmannia auropunctata,
Vollenhovia emeryi and Paratrechina
longicornis — the situation is even
more baroque [9–11]. New queens are
also produced via parthenogenesis
and workers are produced sexually
via hybrid crosses. However, the
hybrid crosses take place between
the maternal lineages and a species
consisting exclusively of males.
These males reproduce by using
females as ‘egg donors’: instead of
developing from unfertilized eggs, as is
usually the case in ants, the sperm
most likely eliminates the maternal
